Rigel Pharmaceuticals (RIGL)

Add to Watchlists
Create an Alert
3.67 -0.31  -7.79% NASDAQ Dec 11, 15:57 Delayed 2m USD

Rigel Pharmaceuticals Cash from Investing (TTM):

17.88M for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Rigel Pharmaceuticals Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Rigel Pharmaceuticals Historical Cash from Investing (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 17.88M
June 30, 2017 20.71M
March 31, 2017 31.50M
Dec. 31, 2016 24.88M
Sept. 30, 2016 35.52M
June 30, 2016 55.77M
March 31, 2016 28.33M
Dec. 31, 2015 44.61M
Sept. 30, 2015 48.78M
June 30, 2015 25.43M
March 31, 2015 61.98M
Dec. 31, 2014 62.93M
Sept. 30, 2014 69.52M
June 30, 2014 77.12M
March 31, 2014 57.07M
Dec. 31, 2013 72.40M
Sept. 30, 2013 -59.37M
June 30, 2013 -55.20M
March 31, 2013 -39.43M
Dec. 31, 2012 -39.03M
Sept. 30, 2012 87.07M
June 30, 2012 56.50M
March 31, 2012 -74.45M
Dec. 31, 2011 -62.85M
Sept. 30, 2011 -104.64M
   
June 30, 2011 -84.27M
March 31, 2011 -39.61M
Dec. 31, 2010 -53.40M
Sept. 30, 2010 -86.78M
June 30, 2010 -100.67M
March 31, 2010 -26.79M
Dec. 31, 2009 -30.66M
Sept. 30, 2009 40.51M
June 30, 2009 78.27M
March 31, 2009 36.38M
Dec. 31, 2008 -26.97M
Sept. 30, 2008 -30.86M
June 30, 2008 -77.46M
March 31, 2008 -61.87M
Dec. 31, 2007 -7.793M
Sept. 30, 2007 -15.03M
June 30, 2007 -0.733M
March 31, 2007 16.86M
Dec. 31, 2006 3.948M
Sept. 30, 2006 -25.30M
June 30, 2006 -12.08M
March 31, 2006 -7.073M
Dec. 31, 2005 -2.151M
Sept. 30, 2005 28.74M
June 30, 2005 23.19M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

RIGL Cash from Investing (TTM) Benchmarks

Benchmarks
Endocyte 43.56M
Catabasis Pharmaceuticals 20.69M
CytomX Therapeutics 70.94M

RIGL Cash from Investing (TTM) Range, Past 5 Years

Minimum -59.37M Sep 2013
Maximum 77.12M Jun 2014
Average 27.07M

RIGL Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("RIGL", "cash_investing_ttm")
  • Last 5 data points: =YCS("RIGL", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.